Establishment Labs Holdings Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 32.61K shares, a 665.42% increase year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 240.35K shares, a 1016.62% increase year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 1.00K shares, a 60.36% decline year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 11.08K shares, a 80.48% decline year-over-year.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 256.70K shares, a 91.24% increase from fiscal 2024.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 134.23K shares, a 61.65% decline from fiscal 2023.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 349.97K shares, a 16.11% increase from fiscal 2022.
- Establishment Labs Holdings Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 301.41K shares, a 42.18% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-03-31 | 32.61K shares 10-Q · filed 2026-05-08 | 285.04K shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | 240.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 256.70K shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 37.87K shares derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-06-30 | 11.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 39.39K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 4.26K shares 10-Q · filed 2025-05-09 | 85.09K shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | 21.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 134.23K shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 2.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 373.38K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 56.78K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 394.70K shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 53.40K shares 10-Q · filed 2024-05-09 | 351.22K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 260.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | 349.97K shares 10-K · filed 2024-03-04 |
| 2023-09-30 | 23.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 145.81K shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 13.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 217.15K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 52.15K shares 10-Q · filed 2023-05-10 | 239.74K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 56.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 301.41K shares 10-K · filed 2023-03-01 |
| 2022-09-30 | 95.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 304.08K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 35.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 471.23K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 113.82K shares 10-Q · filed 2022-05-10 | 472.10K shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 59.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 521.32K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 262.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 521.88K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 36.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | 280.73K shares derived: sum of 4 quarters · filed 2021-07-30 |
| 2021-03-31 | 163.03K shares 10-Q · filed 2021-05-06 | 266.71K shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 59.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | 143.40K shares 10-K · filed 2021-03-15 |
| 2020-09-30 | 21.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 111.59K shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 22.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 115.22K shares derived: sum of 4 quarters · filed 2020-08-07 |
| 2020-03-31 | 39.72K shares 10-Q · filed 2020-05-08 | 114.77K shares derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-12-31 | 27.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 80.99K shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 24.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 59.55K shares derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | 22.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | 54.07K shares derived: sum of 4 quarters · filed 2019-08-13 |
| 2019-03-31 | 5.94K shares 10-Q · filed 2019-05-15 | |
| 2018-12-31 | 6.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | 132.09K shares 10-K · filed 2019-03-20 |
| 2018-09-30 | 19.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2017-12-31 | 0.00 shares 10-K · filed 2019-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |